Problems Related To Software, Heparin Help Push Recalls To All-Time High
This article was originally published in The Gray Sheet
Executive SummaryThe number of recalled medical devices skyrocketed last year to its highest point ever, spurred on by a large volume of recalls related to software and devices containing tainted heparin
You may also be interested in...
US FDA usually recommends using overall survival for pancreatic cancer drugs, but AstraZeneca choose progression-free survival; now ODAC will weigh in on whether the PARP inhibitor olaparib demonstrated a clinically meaningful impact. The firm cites enrollment and design challenges in the gBRCAm population as reasons for using PFS.
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.